Valproate causes reduction of the excitatory amino acid aspartate in nerve terminals

Neuroscience Letters

Volumn 527, Issue 2, 2012, Pages 100-104

  Morland, Cecilie ^a   Nordengen, Kaja ^a   Gundersen, Vidar ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Aspartate; Epilepsy; Excitotoxicity; Nerve terminal; Neurotransmission; Valproate

Indexed keywords

4 AMINOBUTYRIC ACID; ASPARTIC ACID; GLUTAMIC ACID; VALPROIC ACID;

ARTICLE; CYTOCHEMISTRY; DRUG MECHANISM; ELECTRON MICROSCOPY; EPILEPSY; EXCITOTOXICITY; HUMAN; IMMUNOGOLD ELECTRON MICROSCOPY; MENTAL DISEASE; NERVE ENDING; NEUROTRANSMISSION; PRIORITY JOURNAL;

ANIMALS; ANTICONVULSANTS; ASPARTIC ACID; CA3 REGION, HIPPOCAMPAL; MALE; NEUROTRANSMITTER AGENTS; PRESYNAPTIC TERMINALS; RATS; RATS, WISTAR; VALPROIC ACID;

EID: 84866760778     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.08.042     Document Type: Article

References (41)

1. Battistin L., Varotto M., Berlese G., Roman G. Effects of some anticonvulsant drugs on brain GABA level and GAD and GABA-T activities. Neurochemical Research 1984, 9:225-231.
2. Bergersen L.H., Storm-Mathisen J., Gundersen V. Immunogold quantification of amino acids and proteins in complex subcellular compartments. Nature Protocols 2008, 3:144-152.
3. Biggs C.S., Pearce B.R., Fowler L.J., Whitton P.S. The effect of sodium valproate on extracellular GABA and other amino acids in the rat ventral hippocampus: an in vivo microdialysis study. Brain Research 1992, 594:138-142.
4. Broman J., Anderson S., Ottersen O.P. Enrichment of glutamate-like immunoreactivity in primary afferent terminals throughout the spinal cord dorsal horn. European Journal of Neuroscience 1993, 5:1050-1061.
5. 14C]glucose into amino acids. Neurochemical Research 1982, 7:1089-1105.
6. 2+ uptake and amino acid neurotransmitter release in vitro. Epilepsia 1987, 28:378-382.
7. Cunningham M.O., Woodhall G.L., Jones R.S. Valproate modifies spontaneous excitation and inhibition at cortical synapses in vitro. Neuropharmacology 2003, 45:907-917.
8. Curras M.C., Dingledine R. Selectivity of amino acid transmitters acting at N-methyl-d-aspartate and amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors. Molecular Pharmacology 1992, 41:520-526.
9. Gobbi G., Janiri L. Sodium- and magnesium-valproate in vivo modulate glutamatergic and GABAergic synapses in the medial prefrontal cortex. Psychopharmacology 2006, 185:255-262.
10. Godin Y., Heiner L., Mark J., Mandel P. Effects of DI-n-propylacetate, and anticonvulsive compound, on GABA metabolism. Journal of Neurochemistry 1969, 16:869-873.
11. Gundersen V., Chaudhry F.A., Bjaalie J.G., Fonnum F., Ottersen O.P., Storm-Mathisen J. Synaptic vesicular localization and exocytosis of l-aspartate in excitatory nerve terminals: a quantitative immunogold analysis in rat hippocampus. Journal of Neuroscience 1998, 18:6059-6070.
12. Gundersen V., Fonnum F., Ottersen O.P., Storm-Mathisen J. Redistribution of neuroactive amino acids in hippocampus and striatum during hypoglycemia: a quantitative immunogold study. Journal of Cerebral Blood Flow and Metabolism 2001, 21:41-51.
13. Gundersen V., Holten A.T., Storm-Mathisen J. GABAergic synapses in hippocampus exocytose aspartate on to NMDA receptors: quantitative immunogold evidence for co-transmission. Molecular and Cellular Neurosciences 2004, 26:156-165.
14. Hassel B., Bachelard H., Jones P., Fonnum F., Sonnewald U. Trafficking of amino acids between neurons and glia in vivo. Effects of inhibition of glial metabolism by fluoroacetate. Journal of Cerebral Blood Flow and Metabolism 1997, 17:1230-1238.
15. He Y., Hof P.R., Janssen W.G., Rothstein J.D., Morrison J.H. Differential synaptic localization of GluR2 and EAAC1 in the macaque monkey entorhinal cortex: a postembedding immunogold study. Neuroscience Letters 2001, 311:161-164.
16. Hiramatsu M., Kinno I., Kanakura K., Sato K., Mori A. Increased aspartate release from brain slices of epileptic experimental animals and effect of valproate on it. Japanese Journal of Psychiatry and Neurology 1992, 46:541-543.
17. +/dicarboxylate cotransporters. Glia 2008, 56:990-997.
18. Holten A.T., Gundersen V. Glutamine as a precursor for transmitter glutamate, aspartate and GABA in the cerebellum: a role for phosphate-activated glutaminase. Journal of Neurochemistry 2008, 104:1032-1042.
19. Johannessen C.U., Petersen D., Fonnum F., Hassel B. The acute effect of valproate on cerebral energy metabolism in mice. Epilepsy Research 2001, 47:247-256.
20. 13C NMR spectroscopy. Neuroreport 2001, 12:3729-3732.
21. Kukino K., Deguchi T. Effects of sodium dipropylacetate on gamma-aminobutyric acid and biogenic amines in rat brain. Chemical and Pharmaceutical Bulletin 1977, 25:2257-2262.
22. Lai J.C., Walsh J.M., Dennis S.C., Clark J.B. Synaptic and non-synaptic mitochondria from rat brain: isolation and characterization. Journal of Neurochemistry 1977, 28:625-631.
23. Larsson M., Broman J. Different basal levels of CaMKII phosphorylated at Thr286/287 at nociceptive and low-threshold primary afferent synapses. European Journal of Neuroscience 2005, 21:2445-2458.
24. Li Z.P., Zhang X.Y., Lu X., Zhong M.K., Ji Y.H. Dynamic release of amino acid transmitters induced by valproate in PTZ-kindled epileptic rat hippocampus. Neurochemistry International 2004, 44:263-270.
25. Loscher W. In vivo administration of valproate reduces the nerve terminal (synaptosomal) activity of GABA aminotransferase in discrete brain areas of rats. Neuroscience Letters 1993, 160:177-180.
26. Löscher W. Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action. Progress in Neurobiology 1999, 58:31-59.
27. Loscher W., Horstermann D. Differential effects of vigabatrin, gamma-acetylenic GABA, aminooxyacetic acid, and valproate on levels of various amino acids in rat brain regions and plasma. Naunyn-Schmiedebergs Archiv fur Pharmakologie 1994, 349:270-278.
28. Loscher W., Vetter M. Drug-induced changes in GABA content of nerve endings in 11 rat brain regions. Correlation to pharmacological effects. Neuroscience Letters 1984, 47:325-331.
29. Macdonald R.L., Bergey G.K. Valproic acid augments GABA-mediated postsynaptic inhibition in cultured mammalian neurons. Brain Research 1979, 170:558-562.
30. Macdonald R.L., McLean M.J. Anticonvulsant drugs: mechanisms of action. Advances in Neurology 1986, 44:713-736.
31. Monti B., Polazzi E., Contestabile A. Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection. Current Molecular Pharmacology 2009, 2:95-109.
32. Morland C., Boldingh K.A., Iversen E.G., Hassel B. Valproate is neuroprotective against malonate toxicity in rat striatum: an association with augmentation of high-affinity glutamate uptake. Journal of Cerebral Blood Flow and Metabolism 2004, 24:1226-1234.
33. Morland C., Henjum S., Iversen E.G., Skrede K.K., Hassel B. Evidence for a higher glycolytic than oxidative metabolic activity in white matter of rat brain. Neurochemistry International 2007, 50:703-709.
34. Nadler J.V. Aspartate release and signalling in the hippocampus. Neurochemical Research 2011, 36:668-676.
35. Ottersen O.P. Postembedding light- and electron microscopic immunocytochemistry of amino acids: description of a new model system allowing identical conditions for specificity testing and tissue processing. Experimental Brain Research 1987, 69:167-174.
36. Ottersen O.P., Zhang N., Walberg F. Metabolic compartmentation of glutamate and glutamine: morphological evidence obtained by quantitative immunocytochemistry in rat cerebellum. Neuroscience 1992, 46:519-534.
37. Rosenberg G. The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?. Cellular and Molecular Life Sciences 2007, 64:2090-2103.
38. Schechter P.J., Tranier Y., Grove J. Effect of n-dipropylacetate on amino acid concentrations in mouse brain: correlations with anti-convulsant activity. Journal of Neurochemistry 1978, 31:1325-1327.
39. Stahl S.M. Anticonvulsants as mood stabilizers and adjuncts to antipsychotics: valproate, lamotrigine, carbamazepine, and oxcarbazepine and actions at voltage-gated sodium channels. Journal of Clinical Psychiatry 2004, 65:738-739.
40. Takumi Y., Matsubara A., Rinvik E., Ottersen O.P. The arrangement of glutamate receptors in excitatory synapses. Annals of the New York Academy of Sciences 1999, 868:474-482.
41. Wilson N.R., Kang J., Hueske E.V., Leung T., Varoqui H., Murnick J.G., Erickson J.D., Liu G. Presynaptic regulation of quantal size by the vesicular glutamate transporter VGLUT1. Journal of Neuroscience 2005, 25:6221-6234.